25EL-505 On-Demand eCast: HLA 101: Connecting the Dots for Transfusion and Transplant

Credits
1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP) | 1 Physician (PHY)

CABP CE Eligible

Live Program Date: Wednesday, February 12, 2025
Program Number: 25EL-505-L

Educational Track: Technical/Clinical
Topics: Blood Donation & Collection, Patient Transfusion
Intended Audience: Directors, Hospital Blood Banks, Hospitals, Medical Directors, Physicians, Residents/Fellows, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers

Faculty
(titles and affiliations at the time of the live program)
Directors/Moderator: Herleen Rai, MD, Assistant Professor, Department of Pathology, Division of Transfusion Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
Speakers: H. Cliff Sullivan, MD, F(ACHI), Associate Professor, Co-Director, HLA Laboratory, Director, Cellular Therapy Laboratory, Emory University, Atlanta, GA; Deanna Fang, MD, Associate Director of Immunogenetics and Transplantation Laboratory, Associate Director of the Coagulation Laboratory, University of California San Diego (UCSD), San Diego, CA; Indira Guleria, PhD Diplomate (ABHI), CABP(H), Director, Histocompatibility and Immunogenetics (HLA), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA

Program Description
This program offers a deep dive into the critical role of HLA in transfusion medicine and transplant care. The program will introduce participants to the key concepts of HLA, including how it impacts platelet refractoriness and transplant compatibility. Attendees will explore common challenges in applying HLAS knowledge to patient care and learn how to address gaps that can affect treatment outcomes. The program will emphasize practical applications, using case studies to link theoretical knowledge to real-world clinical scenarios.

This 60-minute eCast will feature lecture-style presentations with interactive, case-based discussions. Participants will first be introduced to the foundational concepts and latest testing methodologies. Then, through case studies involving transfusion support and transplant mismatches, attendees will apply the knowledge learned in practical scenarios, helping to solidify clinical and translational insights.

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Define the basics of Human Leukocyte Antigen (HLA) and describe its clinical relevance.
  • Identify common knowledge gaps in HLA knowledge and their impact on patient care.
  • Apply HLA testing methods and clinical insights in real world cases.

How to Claim Continuing Education Credit

  • Single Viewers: if you registered as a single viewer, complete the evaluation found on the "CE Information" tab after watching the video. By submitting the evaluation, you are attesting to watching the presentation in its entirety.
  • Group Viewers: This is applicable for groups/facilities that purchased Group Viewing access for this program (registration will be verified prior to processing a group viewing attendance log). Group Viewing Coordinators should submit the attendance log to eLearning@aabb.org within 72 hours of the completion/viewing date. Once AABB receives an attendance log, each participant on the attendance log will be granted access as a single viewer to this program and will be required to complete the evaluation in order to claim continuing education credit. Each participant will be required to have an AABB account in order to access this program/platform. If a participant does not have an account, he/she can create one using the same email address provided on the attendance log.

Director & Moderator

Speaker Image for Herleen Rai
Johns Hopkins University School of Medicine

Speakers

Speaker Image for H. Cliff Sullivan
H. Cliff Sullivan, MD, F(ACHI)
HLA Laboratory, Cellular Therapy Laboratory, Emory University
Speaker Image for Deanna Fang
University of California San Diego (UCSD)
Speaker Image for Indira Guleria
Indira Guleria, PhD, D(ABHI), CABP(H)
Beth Israel Deaconess Medical Center and Harvard Medical School

Related Products

Thumbnail for AM24-TU-11-O: Managing Risk, Maximizing Safety: The Essentials of Proactive Risk Assessment (Enduring)
AM24-TU-11-O: Managing Risk, Maximizing Safety: The Essentials of Proactive Risk Assessment (Enduring)
This session equips blood bank, transfusion medicine, and biotherapies professionals with practical tools for robust risk assessment. Risk identification methods and customizing risk registers for specific practice areas will be covered…
Thumbnail for AM24-TU-06-O: Oral Abstracts - Biotherapy Spotlight (Enduring)
AM24-TU-06-O: Oral Abstracts - Biotherapy Spotlight (Enduring)
The Biotherapies Spotlight Session will cover several diverse topics. The use of controlled incremental filtration microfluidics rather than monoclonal antibody selection systems to isolate B-cells from whole blood will be discussed…
Thumbnail for AM24-TU-03-O: Addressing Racial Disparities Across Donation Products for Marginalized Peoples (Enduring)
AM24-TU-03-O: Addressing Racial Disparities Across Donation Products for Marginalized Peoples (Enduring)
Despite the need for diverse donors of blood, stem cells, and organs/tissues, such donors remain dramatically underrepresented in donor pools, across donation products.. This session will begin with a brief didactic component, where expert presenters (Dr…
Thumbnail for AM24-MN-34-O: Mechanisms and Technologies Towards Expanding Hematopoietic Stem Cells for Transplantation (Enduring)
AM24-MN-34-O: Mechanisms and Technologies Towards Expanding Hematopoietic Stem Cells for Transplantation (Enduring)
Hematopoietic stem cells (HSCs) are the apex hematopoietic cell with the potential to produce robust and lifelong production of all blood cells. Thus, understanding the details of HSC molecular biology is critical to our understanding of human health and longevity…